Dianna Wu

Title: Dianna Wu: Innovator in Immunohistochemistry

Introduction

Dianna Wu is a prominent inventor based in Skillman, NJ (US). She has made significant contributions to the field of immunohistochemistry, particularly in the detection of programmed death ligand-1 (PD-L1) in tumor tissues. Her work has important implications for cancer diagnostics and treatment.

Latest Patents

Dianna Wu holds a patent for an "Immunohistochemical assay for detecting expression of programmed death ligand 1 (PD-L1) in tumor tissue." This patent outlines processes for describing and quantifying the expression of PD-L1 in tumor tissue sections. The assay utilizes an antibody that specifically binds to PD-L1, providing valuable results for various experimental, diagnostic, and prognostic applications. She has 1 patent to her name.

Career Highlights

Dianna Wu is currently employed at Merck Sharp & Dohme Corp., where she continues to advance her research in immunohistochemistry. Her innovative approaches have contributed to the understanding of tumor biology and the development of targeted therapies.

Collaborations

Throughout her career, Dianna has collaborated with notable colleagues, including Kenneth Emancipator and Frank Lynch. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Dianna Wu's contributions to the field of immunohistochemistry exemplify the impact of innovative research on cancer diagnostics. Her work continues to pave the way for advancements in the understanding and treatment of cancer.